Cover Image

Pattern of disease and response to pembrolizumab in recurrent cervical cancer

Objective: Since the approval of pembrolizumab for advanced or recurrent PD-L1 positive (CPS > 1%) cervical cancer, the clinical characteristics associated with response have remained undefined. We sought to characterize the clinicopathologic features of patients with advanced cervical cancer at...

Full description

Saved in:
Bibliographic Details
Main Authors: Kathryn M. Miller (Author), Olga T. Filippova (Author), Sara A. Hayes (Author), Nadeem R. Abu-Rustum (Author), Carol Aghajanian (Author), Vance Broach (Author), Lora H. Ellenson (Author), Pier Selenica (Author), Elizabeth L. Jewell (Author), Chrisann Kyi (Author), Yuliya Lakhman (Author), Jennifer J. Mueller (Author), Roisin E. O'Cearbhaill (Author), Kay J. Park (Author), Yukio Sonoda (Author), Dmitriy Zamarin (Author), Britta Weigelt (Author), Mario M. Leitao, Jr (Author), Claire F. Friedman (Author)
Format: Book
Published: Elsevier, 2021-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items